These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10458226)

  • 1. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer.
    Chlebowski RT; McTiernan A
    J Clin Oncol; 1999 Jan; 17(1):130-42. PubMed ID: 10458226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
    Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
    Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and breast cancer: revisiting the issues.
    DeGregorio MW; Taras TL
    J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L; Marsden J
    Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
    Fahlén M; Fornander T; Johansson H; Johansson U; Rutqvist LE; Wilking N; von Schoultz E
    Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.
    Welnicka-Jaskiewicz M; Jassem J
    Cancer Treat Rev; 2003 Oct; 29(5):355-61. PubMed ID: 12972354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.
    Armstrong K; Popik S; Guerra C; Ubel PA
    Med Decis Making; 2000; 20(3):308-13. PubMed ID: 10929853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent concerns surrounding HRT.
    Armitage M; Nooney J; Evans S
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in breast cancer survivors.
    Xydakis AM; Sakkas EG; Mastorakos G
    Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.
    Pritchard KI; Khan H; Levine M;
    CMAJ; 2002 Apr; 166(8):1017-22. PubMed ID: 12002977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term risks and benefits of hormone replacement therapy.
    Hillard TC; Whitcroft S; Ellerington MC; Whitehead MI
    J Clin Pharm Ther; 1991 Aug; 16(4):231-45. PubMed ID: 1939402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of aromatase inhibitors: data from clinical trials.
    Howell A; Cuzick J
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):143-9. PubMed ID: 15936188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.
    Armstrong K; Chen TM; Albert D; Randall TC; Schwartz JS
    Obstet Gynecol; 2001 Dec; 98(6):996-1003. PubMed ID: 11755544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.